Span - America Medical Systems (SPAN)
Span - America Medical Systems R&D Expense: 0.18M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
SPAN R&D Expense Rankings
| Overall | 77th percentile | 392 of 1762 |
| Sector | 94th percentile | 22 of 415 in Healthcare |
| Industry | 91st percentile | 6 of 69 in Medical Appliances & Equipment |
SPAN R&D Expense Range, Past 5 Years
| Minimum | 0.14M | Jun 2008 |
| Maximum | 0.29M | Mar 2010 |
| Average | 0.1932M |
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these SPAN related companies
SPAN News
Span-America Raises Dividend for 13th Straight Year: http://stks.co/3tH8 $SPAN
about 14 days ago by DynamicDividend
about 14 days ago by DynamicDividend
Span-America Medical Systems (SPAN) Raises Quarterly Dividend 13.6% to $0.125; 2.9% Yield
May 18, 8:02AM Street Insider
May 18, 8:02AM Street Insider
Span-America Reports Growth in Sales and Net Income for Second Quarter of Fiscal 2012
May 07, 4:01PM Business Wire
May 07, 4:01PM Business Wire
Span-America Medical Systems I (SPAN) Declares $0.11 Quarterly Dividend; 2.7% Yield
Feb 16, 3:39PM Street Insider
Feb 16, 3:39PM Street Insider
$SPAN filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/1yiC
about 135 days ago by MarketBrief
about 135 days ago by MarketBrief
Span-America Medical Systems I (SPAN) Declares $0.11 Quarterly Dividend; 3% Yield
Nov 10, 8:00AM Street Insider
Nov 10, 8:00AM Street Insider
Span-America Announces Fourth Quarter and Fiscal Year-End 2011 Conference Call on the Internet
Nov 08, 7:30AM PR Newswire
Nov 08, 7:30AM PR Newswire
Span-America Announces Fourth Quarter and Fiscal Year-End 2011 Conference Call on the Internet
Oct 27, 11:00AM PR Newswire
Oct 27, 11:00AM PR Newswire
$SPAN, on the other hand, has a 3% dividend and a single digit forward P/E...something to consider.
about 272 days ago by MOFinancial
about 272 days ago by MOFinancial
Span-America ups dividend by 10%. Yields 2.84% with a 12 year dividend growth streak. (Div +340% since 2000.) http://goo.gl/eDxps / $SPAN
about 399 days ago by DynamicDividend
about 399 days ago by DynamicDividend
$SPAN 2010 year in review. still throwing off cash but facing strong headwinds. closing position http://bit.ly/gGdg9g
about 498 days ago by asues
about 498 days ago by asues
$SPAN Q3 Recap - stock took a hit after disappointing quarterly numbers, but seems poised for solid Q4 & year http://bit.ly/aXMQMx
about 668 days ago by asues
about 668 days ago by asues
new post: $SPAN Q2 results. 82 consecutive quarterly dividends & special dividend. stock still undervalued http://bit.ly/9DHn9z
about 738 days ago by asues
about 738 days ago by asues
Bah - didn't notice how low the avg volume on $SPAN has been - buying that today may come back to bite me
about 787 days ago by Stargazer71
about 787 days ago by Stargazer71
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SPAN | 17.51 | +0.01 | +0.06% | 51.10M |
| SPAB | 1.07 | +0.04 | +3.88% | |
| YGE | 2.70 | +0.10 | +3.85% | 378.53M |
| YELP | 15.68 | -1.03 | -6.16% | |
| YDNT | 34.32 | -0.39 | -1.12% | 274.56M |
| YCS | 41.66 | -0.27 | -0.64% | |
| YAVY | 2.65 | -0.18 | -6.36% | 55.27M |
| YAO | 21.73 | +0.06 | +0.28% | |
| Y | 325.31 | -3.69 | -1.12% | 2.813B |
| UNT | 38.65 | -1.14 | -2.87% | 1.935B |
